GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimerix Inc (STU:CXF) » Definitions » Purchase Of Investment

Chimerix (STU:CXF) Purchase Of Investment : €-150.66 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Chimerix Purchase Of Investment?

Chimerix's purchase of investment for the three months ended in Mar. 2024 was €-37.81 Mil. It means Chimerix spent €37.81 Mil on purchasing investments. Chimerix's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €-150.66 Mil.

Compared with last quarter (€-29.05 Mil in Dec. 2023 ), Chimerix spent more money on purchasing investments in Mar. 2024 (€-37.81 Mil).

Chimerix Purchase Of Investment Historical Data

The historical data trend for Chimerix's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimerix Purchase Of Investment Chart

Chimerix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -150.78 -60.81 -101.73 -227.56 -117.83

Chimerix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.35 -35.77 -48.03 -29.05 -37.81

Chimerix Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-150.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chimerix Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Chimerix's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Chimerix (STU:CXF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimerix Inc (STU:CXF) » Definitions » Purchase Of Investment
Comparable Companies
AAGH ACHV VICP SGMT GLYC VERU CUE NKTR ATOS ARMP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CMRX:USA CXF:Germany
Address
2505 Meridian Parkway, Suite 100, Durham, NC, USA, 27713
Website
https://www.chimerix.com
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Chimerix (STU:CXF) Headlines

No Headlines